Thermo Fisher Scientific Inc.
Close on Nov 2, 2026Market cap $252.41BP/E 36.0Yield 0.25%
Thermo Fisher Scientific Organic Revenue Growth by Year
Organic Revenue Growth — Laboratory Products & Biopharma Services (%)
Thermo Fisher Scientific Organic Revenue Growth: 3.0% in FY2025, up 3.0 pts from a year earlier.
Where the FY2025 figure comes from
“LPBS: Organic revenue growth (non-GAAP measure) -1% 3% 3% 5% 3% 4% 5% 10%”
Source: Q3 2026 Reconciliation of Financial Information ↗
Reported in IR Financial Reconciliation Package (Business Segment Information) & SEC MD&A.
Annual history
Hover a value to see the sentence it was read from; calculated values show their formula
| Period | Ended | Organic Revenue Growth — Laboratory Products & Biopharma Services (%) | Year on year | Source |
|---|---|---|---|---|
| FY2025 | Dec 31, 2025 | 3.0% | +3.0 pts | Q3 2026 Reconciliation of Financial Information ↗ |
| FY2024 | Dec 31, 2024 | 0.0% | -2.0 pts | Q4 & FY2025 Reconciliation of Financial Information ↗ |
| FY2023 | Dec 31, 2023 | 2.0% | -8.0 pts | Q4 & FY2024 Reconciliation of Financial Information ↗ |
| FY2022 | Dec 31, 2022 | 10.0% | – | SEC Form 10-K (10k_2022, filed 2023-02-23) ↗ |
Breakdown
What makes up organic Revenue Growth
Cite this data
StockData. (2026). Thermo Fisher Scientific Organic Revenue Growth (%), annual FY2022–FY2025 [Data set]. Compiled from Thermo Fisher Scientific SEC filings and investor materials. https://stockdatahq.com/stocks/tmo/kpis/org-growth-pct-lpbs
See every metric in the Thermo Fisher Scientific KPI table. Data updated Oct 29, 2026.